Low serum tryptophan predicts higher mortality in cardiovascular disease
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background: The essential amino acid tryptophan is required for protein synthesis and formation of the neurotransmitter serotonin and may exert immunoregulatory functions. An accelerated tryptophan breakdown rate is associated with inflammation and immune activation. Materials and methods: Serum concentrations of free tryptophan, neopterin and high‐sensitivity C‐reactive protein (hsCRP) were measured in 1196 patients with coronary artery disease (CAD) derived from the LUdwigshafen RIsk and Cardiovascular Health (LURIC) study. Results: Tryptophan concentrations did not differ between patients with (mean ± SD: 40·1 ± 9·8 μM) or without (42·3 ± 23·9 μM; not significant, Welch's test) angiographic CAD, but patients with CAD had higher neopterin (9·1 ± 8·2 nM) and hsCRP (9·3 ± 18·5 mg/L) concentrations compared to patients without (neopterin: 7·6 ± 4·7 nM, hsCRP: 5·8 ± 7·6 mg/L; both P < 0·0001). There existed an inverse correlation between serum tryptophan and neopterin (Spearman's rank correlation:rs = −0·273) and hsCRP (rs = −0·163; both P < 0·0001) concentrations. Median observation time was 10·5 years, and 385 patients had died, including 244 patients due to cardiovascular and 132 due to noncardiovascular causes. After adjustments for cardiovascular risk factors and other possible confounders, the hazard ratio (with 95% CI) in the first tryptophan quartile of the study population was 1·51 (1·19–1·90;P = 0·0006) for total mortality, 1·41 (1·05–1·89;P = 0·0224) for cardiovascular and 1·79 (1·20–2·67;P = 0·0042) for noncardiovascular mortalities, respectively, thus indicating a significantly higher risk of death in patients with tryptophan concentrations < 34 μM. Conclusions: Low serum tryptophan in patients with CAD is associated with immune activation and indicates reduced life expectancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Inflammation-associated depression: From serotonin to kynurenine
Dantzer, R., O’Connor, J. C., Lawson, M. A., & Kelley, K. W. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.09.012 · Cited by 726
Monitoring tryptophan metabolism in chronic immune activation
Schröcksnadel, K., Wirleitner, B., Winkler, C., & Fuchs, D. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.06.013 · Cited by 551
Self-citationSchroecksnadel, K., Zangerle, R., Bellmann-Weiler, R., Garimorth, K., Weiss, G., & Fuchs, D. (2007) · Current Drug Metabolism · doi:10.2174/138920007780362608 · Cited by 65
Self-citation
Cited by
Analysis, Nutrition, and Health Benefits of Tryptophan
Friedman, M. (2018) · International Journal of Tryptophan Research · doi:10.1177/1178646918802282 · Cited by 292
Strasser, B., Becker, K., Fuchs, D., & Gostner, J. M. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.02.030 · Cited by 97
Self-citationRole of dietary protein and muscular fitness on longevity and aging
Strasser, B., Volaklis, K., Fuchs, D., & Burtscher, M. (2018) · Aging and Disease · doi:10.14336/ad.2017.0202 · Cited by 78
Efferocytosis drives a tryptophan metabolism pathway in macrophages to promote tissue resolution
Sukka, S. R., Ampomah, P. B., Darville, L. N. F., Ngai, D., Wang, X., Kuriakose, G., Xiao, Y., Shi, J., Koomen, J. M., McCusker, R. H., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01115-7 · Cited by 82
“It is also possible that Trp supplementation could achieve the same goal, and several studies have shown that high concentrations of Trp in plasma are associated with a decreased risk of cardiovascular disease 68–70 .”
Metadata
- Authors
- Murr, C., Grammer, T. B., Kleber, M. E., Meinitzer, A., März, W., & Fuchs, D.
- Venue
- European Journal of Clinical Investigation
- Publisher
- Wiley
- Published
- 2015-02-03
- Volume
- 45
- Issue
- 3
- Pages
- 247-254
- ISSN
- 0014-2972 (ISSN-L)
- 1365-2362
- OpenAlex
- W2033524936
- Cited by
- 59
- References
- 4
- FWCI
- 1.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.